Skip to main content
. 2007 Jan 30;14(1):83–90. doi: 10.1007/s00534-006-1160-y

Table 3.

Comparative clinical tests of antimicrobial drugs in cholecystitis

Authors Subjects Antimicrobial Clinical cure rate Significant difference
Muller (1987)17 Cholecystitis ABPC+TOB 11/13 (85%)
Piperacillin 18/19 (95%) NS
Cefoperazone 19/20 (95%) NS
Chacon (1990)18 Cholecystitis + Pefloxacin 49/50 (98%) NS
cholangitis ABPC+GM 45/47(95.7%)
Thompson (1993)19 Cholecystitis + Cefepime 78/80 (97.5%) NS
cholangitis Mezlocillin+GM 40/40 (100%)

ABPC, ampicillin; TOB, tobramycin; GM, gentamicin